Tuesday, November 02, 1999
TRISTATE MARKET SPOTLIGHT
OK on generic boosts Duramed
Duramed Pharmaceuticals gained 75 cents, or 9.2 percent, to close Tuesday at $8.871/2.
The Pleasant Ridge firm said Tuesday that it received approval to sell a generic version of the Ogen brand estrogen-replacement drug made by Upjohn Co. It will begin shipping its estropipate tablets for the treatment of menopausal symptoms in mid-2000.
Duramed had distributed the drug through an agreement with Ortho-McNeil Pharmaceutical. Approval of Duramed's abbreviated new drug application for estropipate allows it to sell its own formulation.
Kroger to buy 74 stores from Winn-Dixie
Welch to exit GE very carefully
INDUSTRY NOTES: RETAIL
TRISTATE MARKET SPOTLIGHT
TRISTATE SUMMARY
Web sites provide shopping research
